Education
About Us
Working with TipRanks
Follow Us
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
RESEARCH TOOLSreports
Total Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$1.53B. The enterprise value is HK$768.85M.
Market CapHK$1.53B
Enterprise ValueHK$768.85M
Share Statistics
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has 236,223,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding236,223,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -8.53%.
Return on Equity (ROE)-0.13
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-8.53%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee0.00
Profits Per Employee-1.40K
Employee Count63
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is -4.26. Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s PEG ratio is 0.12.
PE Ratio-4.26
PS Ratio0.00
PB Ratio1.27
Price to Fair Value0.57
Price to FCF-6.48
Price to Operating Cash Flow-7.90
PEG Ratio0.12
Income Statement
In the last 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had revenue of 0.00 and earned -87.94M in profits. Earnings per share was -0.36.
Revenue0.00
Gross Profit0.00
Operating Income-61.04M
Pretax Income-93.32M
Net Income-87.94M
EBITDA-44.54M
Earnings Per Share (EPS)-0.36
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.54
52-Week Price Change94.68%
50-Day Moving Average2.70
200-Day Moving Average2.07
Relative Strength Index (RSI)63.75
Average Volume (3m)682.20K
Important Dates
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H upcoming earnings date is Aug 1, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 1, 2025
Ex-Dividend Date―
Financial Position
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H as a current ratio of 15.22, with Debt / Equity ratio of 2.05%
Current Ratio15.22
Quick Ratio13.81
Debt to Market Cap0.00
Net Debt to EBITDA4.36
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H EV to EBITDA ratio is -4.06, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-4.06
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has HK$202.39M in cash and marketable securities with ¥8.28M in debt, giving a net cash position of -HK$194.10M billion.
Cash & Marketable SecuritiesHK$202.39M
Total Debt¥8.28M
Net Cash-HK$194.10M
Net Cash Per Share-HK$0.82
Tangible Book Value Per ShareHK$1.64
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast50.94%